Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||
| Net Income | -28,720 | -16,722 | -28,001 |
| Depreciation Amortization | 2,266 | 1,672 | 1,116 |
| Accounts receivable | N/A | -1,612 | -1,692 |
| Accounts payable and accrued liabilities | N/A | 1,514 | -72 |
| Other Working Capital | -28,280 | -27,193 | -3,398 |
| Other Operating Activity | 7,304 | 5,586 | 6,040 |
| Operating Cash Flow | $-47,430 | $-36,755 | $-26,007 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | N/A | -20,685 | -20,371 |
| PPE Investments | -3,258 | -2,622 | -2,443 |
| Other Investing Activity | -22,717 | 0 | 0 |
| Investing Cash Flow | $-25,975 | $-23,307 | $-22,814 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 23,431 | N/A |
| Common Stock Issued | N/A | 10 | 10 |
| Common Stock Repurchased | N/A | -12 | -12 |
| Other Financing Activity | 24,391 | 0 | 0 |
| Financing Cash Flow | $24,391 | $23,429 | $-2 |
| Beginning Cash Position | 102,776 | 102,776 | 102,776 |
| End Cash Position | 53,762 | 66,143 | 53,953 |
| Net Cash Flow | $-49,014 | $-36,633 | $-48,823 |
| Free Cash Flow | |||
| Operating Cash Flow | -47,430 | -36,755 | -26,007 |
| Capital Expenditure | N/A | -2,622 | -2,443 |
| Free Cash Flow | -47,430 | -39,377 | -28,450 |